This is a demo store. No orders will be fulfilled.

Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Vital Signs - The Analyst's Perspective - February 2015 Issue

Vital Signs - The Analyst's Perspective - February 2015 Issue

RELEASE DATE
02-Mar-2015
REGION
North America
Deliverable Type
Market Research
Research Code: 9A35-00-30-00-00
SKU: HC02611-NA-MR_16733
$500.00
In stock
SKU
HC02611-NA-MR_16733
$500.00
DownloadLink
Add to Compare

Pay by invoice

ENQUIRE NOW

Description

This issue of Vital Signs, released on March 2, 2015, discusses the US President's science budget, Pfizer's acquisition of Hospira, China's redefined Foreign Investment Law, and President Obama's Precision Medicine Initiative.

Table of Contents

This week's issue

Request Sample
Popular Topics

nebulizer market

flexible electronics market

glucose monitoring devices market

wearable technology market

vaccine market

smart lighting market

natural flavors market

agrochemicals market

neurology devices market

probiotics market

This market insight provides an analysis of the regulatory trends occurring in the US life sciences market. Included in this deliverable is an analysis of the new molecular entities (NMEs) approved by the US Food and Drug Administration and predictions for 2014. Trends are showing that the Food and Drug Administration is moving towards greater efficiency and expedited review periods which leads to faster access to care.
More Information
Deliverable Types Market Research
No Index No
Podcast No
Author Jennifer Lazar
Industries Healthcare
WIP Number 9A35-00-30-00-00
Is Prebook No